Consumer-product teams deciding what to build, revise, validate, launch, localize, or stop.
Consumer-product teams deciding what to build, revise, validate, launch, localize, or stop.
Use real buyer evidence and consumer agents to compare options before production, inventory, or media spend.
Decision readout
AI consumer research helps teams compare product decisions faster, but it should be used as decision support rather than proof of demand.
Pilot scope
Use real buyer evidence and consumer agents to compare options before production, inventory, or media spend.
NovoChoice combines real consumer evidence, AI-assisted interviews, and reusable consumer agents so teams can pressure-test concepts, claims, packs, prices, listings, and launch plans before larger commitments.
Use this when the team needs a clearer decision before a larger research, production, inventory, or media commitment.
Consumer-product teams deciding what to build, revise, validate, launch, localize, or stop.
Founders, product, research, category, and go-to-market teams that have real materials but need a sharper readout.
Situations where a smaller private pilot can clarify which real-world validation should happen next.
Keep the pilot narrow: one decision, real materials, reviewed consumer signals, and a next-step readout.
Start with a concrete business question, the options on the table, the target market, and the timing pressure.
Use concepts, listings, claims, prices, competitor pages, reviews, or internal notes so the test has context.
Consumer agents grounded in real signals compare acceptance, objections, proof needs, and likely next questions.
The readout separates what looks actionable from what still needs real validation before spend.
The output is meant to help the team decide what to revise, validate, or stop next.
A reviewed summary of the recommended route, supporting signals, unresolved risks, and next validation step.
A plain-language map of consumer doubts, trust gaps, proof needs, and confusing claims.
A focused recommendation for what should be validated with real consumers, channel data, or a smaller live test.
NovoChoice is decision support. It should not be presented as sales proof, representative measurement, legal substantiation, or a substitute for final consumer validation.
Using AI output as final sales proof, representative survey data, legal substantiation, or a replacement for final real-world validation.
Decisions that require clinical, regulatory, safety, or compliance approval before consumer interpretation is useful.
Answers before you scope a pilot.
No. NovoChoice starts from real evidence and helps teams decide what deserves the next real validation.
Useful materials include product concepts, claims, images, pricing, packaging, listings, reviews, competitor pages, and target audience notes.
No. NovoChoice identifies likely consumer reactions, objections, proof gaps, and next validation needs; it does not guarantee demand or sales.
Share the current options, materials, target market, and timing. NovoChoice will scope whether a focused private pilot is useful.